Live Breaking News & Updates on சிகிச்சை டோஸ்

Stay updated with breaking news from சிகிச்சை டோஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pivotal Phase 3 SIERRA Trial Data Showing 100% Bone Marrow Transplant Engraftment in Patients Treated with Iomab-B presented at the 2021 Virtual SNMMI Conference

Pivotal Phase 3 SIERRA Trial Data Showing 100% Bone Marrow Transplant Engraftment in Patients Treated with Iomab-B presented at the 2021 Virtual SNMMI Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Susan-passalaqua , Hans-vitzthum , Mark-berger , Company-phase , Lifesci-advisors , Exchange-commission , Astellas-pharma-inc , Actinium-pharmaceuticals-inc , Banner-md-anderson-cancer-center , Society-of-nuclear-medicine , Memorial-sloan-kettering-cancer-center

Theralase Releases Q12021 Interim Financial Statements

TORONTO, May 28, 2021 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage…

Canada , United-states , Toronto , Ontario , Canadian , Good-laboratory-practices , Collaborative-research-agreement , Development-expenses , Technologies-inc , Public-health-agency-of-canada , National-microbiology-laboratory

Theralase Release FY2020 Audited Financial Statements

Theralase Release FY2020 Audited Financial Statements
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , Toronto , Ontario , Canadian , Good-laboratory-practices , Collaborative-research-agreement , Technologies-inc , Public-health-agency-of-canada , National-microbiology-laboratory , Regulation-services-provider

Theralase Release FY2020 Audited Financial Statements

Theralase Release FY2020 Audited Financial Statements
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , Toronto , Ontario , Canadian , Good-laboratory-practices , Collaborative-research-agreement , Technologies-inc , Public-health-agency-of-canada , National-microbiology-laboratory , Regulation-services-provider

Theralase Technologies Inc.: Theralase Releases Quarterly Newsletter


Theralase Technologies Inc.: Theralase Releases Quarterly Newsletter
® Technologies Inc. ("
TSXV:TLT)(
OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds ("
PDC") and associated drug formulations to safely and effectively destroy various cancers, bacteria and viruses has released the Company's Quarterly Newsletter ("
Newsletter") which provides updates on the previous quarter and progress on the Phase II Non-Muscle Invasive Bladder Cancer ("
NMIBC") Clinical Study ("
Highlights from the Newsletter:
Clinical Study Sites ("CSS")
11 CSS's have been launched in Canada (5) and the US (6) for patient enrollment and treatment for Study II.
Patients Treated
Study II has enrolled and provided the primary study treatment for 18 patients (

Toronto , Ontario , Canada , Canadian , Kristina-hachey , Technologies-inc , Company-quarterly-newsletter , Venture-exchange , Regulation-services-provider , Photo-dynamic-compounds , Quarterly-newsletter , Muscle-invasive-bladder-cancer

COVID-пандемия: врач объяснил, нужно ли принимать витамин С | Новости здоровья в Харькове, Украине. Весь Харьков

COVID-пандемия: врач объяснил, нужно ли принимать витамин С | Новости здоровья в Харькове, Украине. Весь Харьков
allkharkov.ua - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allkharkov.ua Daily Mail and Mail on Sunday newspapers.

Russia , With-vitamin-may , Therapeutic-dose , Shtml-punished-the , With-respect , First-channel , Russia-president-signed , ரஷ்யா , சிகிச்சை-டோஸ் , உடன்-மரியாதை , முதல்-சேனல்

COVID-пандемия: врач объяснил, нужно ли принимать витамин С | Новости Харькова и Украины

COVID-пандемия: врач объяснил, нужно ли принимать витамин С | Новости Харькова и Украины
atn.ua - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from atn.ua Daily Mail and Mail on Sunday newspapers.

Ukraine , Therapeutic-dose , உக்ரைன் , சிகிச்சை-டோஸ் ,

COVID-пандемия: врач объяснил, нужно ли принимать витамин С | Новости в Харькове, Украине. Весь Харьков

COVID-пандемия: врач объяснил, нужно ли принимать витамин С | Новости в Харькове, Украине. Весь Харьков
allkharkov.ua - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allkharkov.ua Daily Mail and Mail on Sunday newspapers.

Moscow , Moskva , Russia , Atlantic-council , With-vitamin-may , Therapeutic-dose , Html-view , Minister-has-called , மாஸ்கோ , மோசிக்குவா , ரஷ்யா

Theralase Launches Second Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study


Press release content from Accesswire. The AP news staff was not involved in its creation.
Theralase Launches Second Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study
January 20, 2021 GMT
TORONTO, ON / ACCESSWIRE / January 20, 2021 / Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (“PDC”) and their associated drug formulations used to safely and effectively destroy various cancers, bacteria and viruses announced today that Urology Associates P.C. (“UA”) has received site Institutional Review Board (“IRB”) approval to commence a pivotal phase II Non-Muscle Invasive Bladder Cancer (“NMIBC”) Clinical Study to enroll and treat patients with Bacillus Calmette Guerin(“BCG”)-Unresponsive Carcinoma In-Situ (“CIS”) or are intolerant to BCG Therapy (“Study II”).

Tennessee , United-states , Canada , Toronto , Ontario , Canadian , Gautam-jayram , Kristina-hachey , Calmette-guerin , Urology-associates , Therapeutic-center , Theralase-or-company